Interleukin-15 antagonist peptide
Details for Australian Patent Application No. 2005284529 (hide)
International Classifications
Event Publications
10 May 2007 PCT application entered the National Phase
PCT publication WO2006/029578 Priority application(s): WO2006/029578
25 November 2010 Application Accepted
Published as AU-B-2005284529 (Modified Examination)
17 March 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 17 Feb 2011. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
7 July 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 17 Feb and 2 Mar 2011
1 September 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005284554-Seawater desalination plant
2005284528-Methods and compositions for the treatment of hyperlipidemia
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser